{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:21:01Z","timestamp":1793830861819,"version":"4.6.1"},"reference-count":48,"publisher":"American Society of Hematology","issue":"25","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,6,19]]},"abstract":"<jats:sec>\n                  <jats:title>Abstract<\/jats:title>\n                  <jats:p>Whether allogeneic hematopoietic cell transplant (allo-HCT) to treat acute myeloid leukemia (AML) is equitably accessible regardless of social determinants of health (SDOH) remains unknown. We examined associations of SDOH with access to allo-HCT and other outcomes. Patients presenting for treatment (n = 692) at 13 AML treatment centers were prospectively recruited to a registered clinical trial (number NCT01929408). Various patient-, AML-, and SDOH-specific variables were collected. Outcomes included mortality without allo-HCT, receipt of allo-HCT, and mortality after allo-HCT. Individual multivariable models (Fine-Gray for the first 2 outcomes, Cox regression for the third) were fit for each SDOH variable, adjusting for relevant patient- and AML-specific variables. Allo-HCT was used to treat 46% of patients. A 10% increase in the proportion with less than a high school education, in households receiving Supplemental Nutrition Assistance Program, receiving Supplemental Security Income, or in poverty led to modeled adjusted hazard ratios (aHRs) of 1.21 (0.99-1.46), 1.13 (0.97-1.31), 1.41 (1.01-1.97), and 1.16 (0.96-1.39) for death without allo-HCT. The aHRs were 0.67 (0.55-0.83), 0.88 (0.76-1.01), 0.71 (0.48-1.05), and 0.91 (0.75-1.09) for lessened receipt of allo-HCT. Among those who received allo-HCT, aHRs for mortality were 1.18 (0.87-1.60), 1.13 (0.92-1.38), 1.21 (0.81-1.82), and 1.04 (0.79-1.36). Results highlight increased mortality without allo-HCT and decreased access to allo-HCT, but lesser magnitude of increased mortality after allo-HCT, among patients from lower resourced areas due to limited education and\/or increased poverty. Targeted interventions and policy changes are needed to ensure that marginalized patient populations have equitable chances for AML cure compared with others.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1182\/blood.2024027543","type":"journal-article","created":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T14:04:39Z","timestamp":1741701879000},"page":"3041-3051","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":21,"title":["Social determinants of health and access to allogeneic hematopoietic cell transplantation for acute myeloid leukemia"],"prefix":"10.1182","volume":"145","author":[{"given":"Natalie","family":"Wuliji","sequence":"first","affiliation":[{"name":"1Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA"},{"name":"2Division of Hematology and Oncology, University of Washington School of Medicine, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2140-5798","authenticated-orcid":false,"given":"Salene M. W.","family":"Jones","sequence":"additional","affiliation":[{"name":"3Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ted","family":"Gooley","sequence":"additional","affiliation":[{"name":"1Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3422-1309","authenticated-orcid":false,"given":"Aaron T.","family":"Gerds","sequence":"additional","affiliation":[{"name":"4Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno C.","family":"Medeiros","sequence":"additional","affiliation":[{"name":"5Division of Hematology, Department of Medicine, Stanford University, Stanford, Palo Alto, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Shami","sequence":"additional","affiliation":[{"name":"6Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Galvin","sequence":"additional","affiliation":[{"name":"7University of Illinois Chicago Cancer Center, Chicago, IL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7166-9308","authenticated-orcid":false,"given":"Kehinde","family":"Adekola","sequence":"additional","affiliation":[{"name":"8Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selina","family":"Luger","sequence":"additional","affiliation":[{"name":"9Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria R.","family":"Baer","sequence":"additional","affiliation":[{"name":"10University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Rizzieri","sequence":"additional","affiliation":[{"name":"11Novant Heath, Cancer Institute, Charlotte, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya M.","family":"Wildes","sequence":"additional","affiliation":[{"name":"12Division of Oncology and Hematology, University of Nebraska Medical Center, Omaha, NE"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8644-0968","authenticated-orcid":false,"given":"Eunice S.","family":"Wang","sequence":"additional","affiliation":[{"name":"13Leukemia Service, Roswell Park Comprehensive Cancer Center, Buffalo, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2009-6524","authenticated-orcid":false,"given":"Mikkael A.","family":"Sekeres","sequence":"additional","affiliation":[{"name":"14University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudipto","family":"Mukherjee","sequence":"additional","affiliation":[{"name":"4Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Smith","sequence":"additional","affiliation":[{"name":"15Confluence Health\/Wenatchee Valley Hospital and Clinic, Wenatchee, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell","family":"Garrison","sequence":"additional","affiliation":[{"name":"15Confluence Health\/Wenatchee Valley Hospital and Clinic, Wenatchee, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiarash","family":"Kojouri","sequence":"additional","affiliation":[{"name":"16Skagit Valley Hospital, Mount Vernon, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4362-7773","authenticated-orcid":false,"given":"Jacob","family":"Appelbaum","sequence":"additional","affiliation":[{"name":"1Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA"},{"name":"2Division of Hematology and Oncology, University of Washington School of Medicine, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary-Elizabeth","family":"Percival","sequence":"additional","affiliation":[{"name":"1Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA"},{"name":"2Division of Hematology and Oncology, University of Washington School of Medicine, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9767-9739","authenticated-orcid":false,"given":"Brenda M.","family":"Sandmaier","sequence":"additional","affiliation":[{"name":"2Division of Hematology and Oncology, University of Washington School of Medicine, Seattle, WA"},{"name":"17Translation Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2600-6390","authenticated-orcid":false,"given":"Stephanie","family":"Lee","sequence":"additional","affiliation":[{"name":"1Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA"},{"name":"2Division of Hematology and Oncology, University of Washington School of Medicine, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick R.","family":"Appelbaum","sequence":"additional","affiliation":[{"name":"1Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA"},{"name":"2Division of Hematology and Oncology, University of Washington School of Medicine, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rayne","family":"Rouce","sequence":"additional","affiliation":[{"name":"18Section of Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed L.","family":"Sorror","sequence":"additional","affiliation":[{"name":"1Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA"},{"name":"2Division of Hematology and Oncology, University of Washington School of Medicine, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2025061911211859500_bib1","volume-title":"A Conceptual Framework for Action on the Social Determinants of Health","author":"Solar","year":"2007"},{"issue":"9464","key":"2025061911211859500_bib2","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S0140-6736(05)71146-6","article-title":"Social determinants of health inequalities","volume":"365","author":"Marmot","year":"2005","journal-title":"Lancet"},{"issue":"6","key":"2025061911211859500_bib3","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1371\/journal.pmed.0030106","article-title":"The commission on social determinants of health: tackling the social roots of health inequities","volume":"3","author":"Irwin","year":"2006","journal-title":"PLoS Med"},{"issue":"2","key":"2025061911211859500_bib4","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/1468-0009.12390","article-title":"Meanings and misunderstandings: a social determinants of health lexicon for health care systems","volume":"97","author":"Alderwick","year":"2019","journal-title":"Milbank Q"},{"issue":"3","key":"2025061911211859500_bib5","doi-asserted-by":"crossref","first-page":"e200618","DOI":"10.1001\/jamanetworkopen.2020.0618","article-title":"Association of neighborhood measures of social determinants of health with breast, cervical, and colorectal cancer screening rates in the US Midwest","volume":"3","author":"Kurani","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"1","key":"2025061911211859500_bib6","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1056\/NEJMp1512532","article-title":"Accountable health communities--addressing social needs through Medicare and Medicaid","volume":"374","author":"Alley","year":"2016","journal-title":"N Engl J Med"},{"issue":"8","key":"2025061911211859500_bib7","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1056\/NEJMp1413945","article-title":"Patients in context--EHR capture of social and behavioral determinants of health","volume":"372","author":"Adler","year":"2015","journal-title":"N Engl J Med"},{"issue":"10","key":"2025061911211859500_bib8","doi-asserted-by":"crossref","first-page":"e2016852","DOI":"10.1001\/jamanetworkopen.2020.16852","article-title":"Comparison of community-level and patient-level social risk data in a network of community health centers","volume":"3","author":"Cottrell","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"7","key":"2025061911211859500_bib9","doi-asserted-by":"crossref","first-page":"447","DOI":"10.6004\/jnccn.2024.7027","article-title":"Evaluation of socioeconomic and racial\/ethnic disparities in all-cause mortality in adolescents and young adults with cancer","volume":"22","author":"Henderson","year":"2024","journal-title":"J Natl Compr Canc Netw"},{"key":"2025061911211859500_bib10","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1186\/s12885-015-1997-z","article-title":"Cumulative social risk exposure and risk of cancer mortality in adulthood","volume":"15","author":"Caleyachetty","year":"2015","journal-title":"BMC Cancer"},{"issue":"7","key":"2025061911211859500_bib11","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.clml.2021.02.001","article-title":"The impact of socioeconomic risk factors on the survival outcomes of patients with newly diagnosed multiple myeloma: a cross-analysis of a population-based registry and a tertiary care center","volume":"21","author":"Evans","year":"2021","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"1","key":"2025061911211859500_bib12","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/cncr.33894","article-title":"Social determinants of health and cancer mortality in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) cohort study","volume":"128","author":"Pinheiro","year":"2022","journal-title":"Cancer"},{"issue":"9","key":"2025061911211859500_bib13","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1200\/JCO.2015.64.6620","article-title":"Financial insolvency as a risk factor for early mortality among patients with cancer","volume":"34","author":"Ramsey","year":"2016","journal-title":"J Clin Oncol"},{"issue":"6","key":"2025061911211859500_bib14","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1007\/s11606-020-06479-6","article-title":"Association of financial worry and material financial risk with short-term ambulatory healthcare utilization in a sample of subsidized exchange patients","volume":"36","author":"Jones","year":"2021","journal-title":"J Gen Intern Med"},{"issue":"10","key":"2025061911211859500_bib15","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/s41409-018-0164-y","article-title":"Socioeconomic and health system factors associated with lower utilization of hematopoietic cell transplantation in older patients with acute myeloid leukemia","volume":"53","author":"Bhatt","year":"2018","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"2025061911211859500_bib16","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/ejh.14129","article-title":"Utilization and outcome disparities in allogeneic hematopoietic stem cell transplant in the United States","volume":"112","author":"Ashok Kumar","year":"2024","journal-title":"Eur J Haematol"},{"issue":"12","key":"2025061911211859500_bib17","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1016\/j.bbmt.2020.09.013","article-title":"Barriers to hematopoietic cell transplantation for adults in the United States: a systematic review with a focus on age","volume":"26","author":"Flannelly","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"2025061911211859500_bib18","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.3389\/fpubh.2021.699049","article-title":"Poverty, racism, and the public health crisis in America","volume":"9","author":"Beech","year":"2021","journal-title":"Front Public Health"},{"issue":"6","key":"2025061911211859500_bib19","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1056\/NEJMms2211450","article-title":"The social determinants of health - moving beyond screen-and-refer to intervention","volume":"389","author":"Vanjani","year":"2023","journal-title":"N Engl J Med"},{"issue":"3","key":"2025061911211859500_bib20","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1007\/s40615-023-01611-8","article-title":"Evaluating socioeconomic, racial, and ethnic disparities in survival among patients undergoing allogeneic hematopoietic stem cell transplants","volume":"11","author":"Garcia","year":"2024","journal-title":"J Racial Ethn Health Disparities"},{"issue":"6","key":"2025061911211859500_bib21","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/bmt.2012.248","article-title":"Pilot study of patient and caregiver out-of-pocket costs of allogeneic hematopoietic cell transplantation","volume":"48","author":"Majhail","year":"2013","journal-title":"Bone Marrow Transplant"},{"issue":"19","key":"2025061911211859500_bib22","doi-asserted-by":"crossref","first-page":"5146","DOI":"10.1182\/bloodadvances.2024012998","article-title":"Addressing financial hardship in malignant hematology and hematopoietic cell transplant: a team approach","volume":"8","author":"Jones","year":"2024","journal-title":"Blood Adv"},{"key":"2025061911211859500_bib23","first-page":"177","article-title":"The racial wealth gap","volume":"175","author":"Shapiro","year":"2005","journal-title":"Afr Americans US economy"},{"issue":"4","key":"2025061911211859500_bib24","doi-asserted-by":"crossref","first-page":"e0174760","DOI":"10.1371\/journal.pone.0174760","article-title":"Sociodemographic disparities in chemotherapy and hematopoietic cell transplantation utilization among adult acute lymphoblastic and acute myeloid leukemia patients","volume":"12","author":"Jabo","year":"2017","journal-title":"PLoS One"},{"issue":"7","key":"2025061911211859500_bib25","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1182\/bloodadvances.2018028662","article-title":"Racial disparities in access to HLA-matched unrelated donor transplants: a prospective 1312-patient analysis","volume":"3","author":"Barker","year":"2019","journal-title":"Blood Adv"},{"issue":"1","key":"2025061911211859500_bib26","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.maturitas.2009.03.011","article-title":"The EQUATOR Network and reporting guidelines: helping to achieve high standards in reporting health research studies","volume":"63","author":"Simera","year":"2009","journal-title":"Maturitas"},{"issue":"9596","key":"2025061911211859500_bib27","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"issue":"4","key":"2025061911211859500_bib28","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","article-title":"Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel","volume":"129","author":"D\u00f6hner","year":"2017","journal-title":"Blood"},{"issue":"5","key":"2025061911211859500_bib29","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1182\/blood.2020008812","article-title":"Multisite 11-year experience of less-intensive vs intensive therapies in acute myeloid leukemia","volume":"138","author":"Sorror","year":"2021","journal-title":"Blood"},{"issue":"3","key":"2025061911211859500_bib30","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1182\/blood.2022016916","article-title":"An 8-year pragmatic observation evaluation of the benefits of allogeneic HCT in older and medically infirm patients with AML","volume":"141","author":"Sorror","year":"2023","journal-title":"Blood"},{"issue":"29","key":"2025061911211859500_bib31","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1200\/JCO.2013.53.8157","article-title":"Comorbidity-age index: a clinical measure of biologic age before allogeneic hematopoietic cell transplantation","volume":"32","author":"Sorror","year":"2014","journal-title":"J Clin Oncol"},{"issue":"9","key":"2025061911211859500_bib32","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1002\/cncr.23375","article-title":"Hematopoietic cell transplantation-comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic nonmyeloablative hematopoietic cell transplantation","volume":"112","author":"Sorror","year":"2008","journal-title":"Cancer"},{"key":"2025061911211859500_bib33","first-page":"199","volume-title":"Evaluation of Chemotherapeutic Agents","author":"Karnofsky","year":"1949"},{"issue":"9","key":"2025061911211859500_bib34","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9: validity of a brief depression severity measure","volume":"16","author":"Kroenke","year":"2001","journal-title":"J Gen Intern Med"},{"key":"2025061911211859500_bib35","author":"Fillenbaum","year":"2013"},{"issue":"2","key":"2025061911211859500_bib36","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1442-2018.2011.00605.x","article-title":"Correlation between a self-administered walk test and a standardised six minute walk test in adults","volume":"13","author":"Du","year":"2011","journal-title":"Nurs Health Sci"},{"issue":"3","key":"2025061911211859500_bib37","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1200\/JCO.1993.11.3.570","article-title":"The Functional Assessment of Cancer Therapy scale: development and validation of the general measure","volume":"11","author":"Cella","year":"1993","journal-title":"J Clin Oncol"},{"issue":"9","key":"2025061911211859500_bib38","doi-asserted-by":"crossref","first-page":"e2433145","DOI":"10.1001\/jamanetworkopen.2024.33145","article-title":"Use of hematopoietic cell transplant for hematologic cancers by race, ethnicity, and age","volume":"7","author":"Hahn","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"9","key":"2025061911211859500_bib39","doi-asserted-by":"crossref","first-page":"917.e1","DOI":"10.1016\/j.jtct.2024.06.021","article-title":"Current trends and outcomes in cellular therapy activity in the United States, including prospective patient-reported outcomes data collection in the Center for International Blood and Marrow Transplant Research Registry","volume":"30","author":"Cusatis","year":"2024","journal-title":"Transplant Cell Ther"},{"issue":"10","key":"2025061911211859500_bib40","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1016\/j.bbmt.2019.06.012","article-title":"Inferior access to allogeneic transplant in disadvantaged populations: a Center for International Blood and Marrow Transplant research analysis","volume":"25","author":"Paulson","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"2025061911211859500_bib41","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/s41375-024-02172-3","article-title":"Impact of socioeconomic disparities on outcomes in adults undergoing allogeneic hematopoietic cell transplantation for acute myeloid leukemia","volume":"38","author":"Olivieri","year":"2024","journal-title":"Leukemia"},{"issue":"12","key":"2025061911211859500_bib42","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.jtct.2022.09.020","article-title":"The ASTCT-NMDP ACCESS Initiative: a collaboration to address and sustain equal outcomes for all across the hematopoietic cell transplantation and cellular therapy ecosystem","volume":"28","author":"Auletta","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"2025061911211859500_bib43","doi-asserted-by":"crossref","first-page":"1179320","DOI":"10.3389\/fpsyg.2023.1179320","article-title":"Guaranteed Income and Financial Treatment Trial (GIFT Trial or GIFTT): a 12-month, randomized controlled trial to compare the effectiveness of monthly unconditional cash transfers to treatment as usual in reducing financial toxicity in people with cancer who have low incomes","volume":"14","author":"Doherty","year":"2023","journal-title":"Front Psychol"},{"issue":"2","key":"2025061911211859500_bib44","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1093\/jopart\/muad023","article-title":"Administrative burden in citizen\u2013state interactions: a systematic literature review","volume":"34","author":"Halling","year":"2023","journal-title":"J Public Adm Res Theor"},{"key":"2025061911211859500_bib45","unstructured":"Savin\n              K\n            \n          . EMF22-01: assessing administrative burden among supplemental security income recipients. Accessed 31 October 2024. https:\/\/rdrc.wisc.edu\/files\/working-papers\/WI-EMF22-01_Paper_Savin_8.24.23.pdf."},{"issue":"4","key":"2025061911211859500_bib46","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/NCC.0000000000001012","article-title":"Evaluation of a nurse-led patient navigation intervention: follow-up of patients after autologous and allogeneic stem cell transplantation","volume":"45","author":"van der Lans","year":"2022","journal-title":"Cancer Nurs"},{"issue":"suppl 1","key":"2025061911211859500_bib47","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1182\/blood-2024-200833","article-title":"Likelihood of finding an 8\/8 HLA-matched unrelated donor (donor search prognosis) is not associated with survival: primary results from BMT CTN 1702 [abstract]","volume":"144","author":"Lee","year":"2024","journal-title":"Blood"},{"key":"2025061911211859500_bib48","unstructured":"U.S. Centers for Medicare and Medicaid Services\n          . Principal illness navigation services: Centers for Medicare and Medicaid Services. Accessed 14 October 2024. https:\/\/www.medicare.gov\/coverage\/principal-illness-navigation-services."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/doi\/10.1182\/blood.2024027543\/2380164\/blood_bld-2024-027543-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/doi\/10.1182\/blood.2024027543\/2380164\/blood_bld-2024-027543-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T15:21:28Z","timestamp":1750346488000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/145\/25\/3041\/535978\/Social-determinants-of-health-and-access-to"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,19]]},"references-count":48,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2025,6,19]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2024027543","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,6,19]]},"published":{"date-parts":[[2025,6,19]]}}}